NCT02431273View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Human Immunodeficiency Virus (HIV) Prophylaxis
Interventions
DRUG

TDF IVR

DRUG

TDF-FTC IVR

DRUG

TDF-FTC-MVC IVR

Trial Locations (1)

77555-0587

University of Texas Medical Branch, Galveston

Sponsors
All Listed Sponsors
collaborator

The University of Texas Medical Branch, Galveston

OTHER

collaborator

Oak Crest Institute of Science

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Auritec Pharmaceuticals

INDUSTRY

NCT02431273 - Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women | Biotech Hunter | Biotech Hunter